Biotech companies now using CEOs as human guinea pigs for new drugs

px Assorted pharmaceuticals by LadyofProcrastination
Image Credit: Wikimedia Commons /Flickr/LadyofProcrastination CC BY-SA 2.0

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis.

As CEO of biotech company Insilico Medicine, Alex Zhavoronkov routinely subjects himself to his own medicine. Self-experimentation lets him quickly see whether lab predictions hold true in a human subject, or whether there are any safety issues.

Such experiments are one of medicine’s oldest traditions. Many a vaccine or poison was first tested on its developer. As medicine has progressed, however, self-experimentation has become less popular in academic labs, to be taken up instead by a growing biotech industry. Those changes have given rise to a new breed of self-tester: the guinea pig CEO.

Self-experiments may hold particular appeal for biomedicine these days. Alongside the rise of personalized medicine, experiments on just one person suddenly become just the right size. Self-experimentation could also let a researcher “leapfrog” millions in developmental costs by getting a new drug straight into human testing and avoiding rounds of tests on animals.

Meanwhile, Zhavoronkov plans to bring more rigor to self-experimentation by starting a journal to peer-review and publish these kinds of studies.

Read full, original post: Biotech execs in search of human guinea pigs find eager subjects: themselves

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}
screenshot at  pm

Are pesticide residues on food something to worry about?

In 1962, Rachel Carson’s Silent Spring drew attention to pesticides and their possible dangers to humans, birds, mammals and the ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.